{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:08Z","timestamp":1786982168895,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Natural Science Basic Research Program of Shaanxi","award":["2024JC-YBMS-704"],"award-info":[{"award-number":["2024JC-YBMS-704"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s12010-026-05621-0","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T06:54:41Z","timestamp":1774940081000},"page":"4898-4914","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SASH1 Inhibits Gastric Cancer Progression by Regulating YAP1-Mediated Metabolic Reprogramming"],"prefix":"10.1007","volume":"198","author":[{"given":"Ting","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guisheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"5621_CR1","doi-asserted-by":"publisher","first-page":"960539","DOI":"10.3389\/fonc.2022.960539","volume":"12","author":"Y Yang","year":"2022","unstructured":"Yang, Y., Meng, W. J., & Wang, Z. Q. (2022). The origin of gastric cancer stem cells and their effects on gastric cancer: Novel therapeutic targets for gastric cancer. Frontiers in Oncology, 12, 960539. https:\/\/doi.org\/10.3389\/fonc.2022.960539","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"5621_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5114\/pg.2018.80001","volume":"14","author":"P Rawla","year":"2019","unstructured":"Rawla, P., & Barsouk, A. (2019). Epidemiology of gastric cancer: Global trends, risk factors and prevention. Prz Gastroenterol, 14(1), 26\u201338. https:\/\/doi.org\/10.5114\/pg.2018.80001","journal-title":"Prz Gastroenterol"},{"key":"5621_CR3","doi-asserted-by":"crossref","unstructured":"Khorovodov, A. P., Agranovich, I. M., Navolokin, N. A., et al. (Eds.). (2020). Detection of early gastric cancer with wavelets. Saratov fall meeting 2019: Computations and data analysis: From nanoscale tools to brain functions. SPIE.","DOI":"10.1117\/12.2559693"},{"key":"5621_CR4","doi-asserted-by":"publisher","first-page":"744839","DOI":"10.3389\/fmed.2021.744839","volume":"8","author":"ZD Chen","year":"2021","unstructured":"Chen, Z. D., Zhang, P. F., Xi, H. Q., et al. (2021). Recent advances in the Diagnosis, Staging, Treatment, and prognosis of advanced gastric cancer: A literature review. Front Med (Lausanne), 8, 744839. https:\/\/doi.org\/10.3389\/fmed.2021.744839","journal-title":"Front Med (Lausanne)"},{"key":"5621_CR5","doi-asserted-by":"publisher","unstructured":"Navarro, C., Ortega, \u00c1., Santeliz, R., et al. (2022). Metabolic reprogramming in cancer cells: Emerging molecular mechanisms and novel therapeutic approaches. Pharmaceutics, 14(6). https:\/\/doi.org\/10.3390\/pharmaceutics14061303","DOI":"10.3390\/pharmaceutics14061303"},{"issue":"5","key":"5621_CR6","doi-asserted-by":"publisher","first-page":"e1600200","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis, R. J., & Chandel, N. S. (2016). Fundamentals of cancer metabolism. Science Advances, 2(5), e1600200. https:\/\/doi.org\/10.1126\/sciadv.1600200","journal-title":"Science Advances"},{"issue":"1","key":"5621_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/br.2017.1022","volume":"8","author":"A Sreedhar","year":"2018","unstructured":"Sreedhar, A., & Zhao, Y. (2018). Dysregulated metabolic enzymes and metabolic reprogramming in cancer cells. Biomed Rep, 8(1), 3\u201310. https:\/\/doi.org\/10.3892\/br.2017.1022","journal-title":"Biomed Rep"},{"issue":"4","key":"5621_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrc2817","volume":"10","author":"DA Tennant","year":"2010","unstructured":"Tennant, D. A., Dur\u00e1n, R. V., & Gottlieb, E. (2010). Targeting metabolic transformation for cancer therapy. Nature Reviews Cancer, 10(4), 267\u2013277. https:\/\/doi.org\/10.1038\/nrc2817","journal-title":"Nature Reviews Cancer"},{"issue":"3","key":"5621_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41419-022-04632-z","volume":"13","author":"H Jiang","year":"2022","unstructured":"Jiang, H., Wei, H., Wang, H., et al. (2022). Zeb1-induced metabolic reprogramming of Glycolysis is essential for macrophage polarization in breast cancer. Cell Death and Disease, 13(3), 206. https:\/\/doi.org\/10.1038\/s41419-022-04632-z","journal-title":"Cell Death and Disease"},{"issue":"2","key":"5621_CR10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00018-019-03278-z","volume":"77","author":"J Yang","year":"2020","unstructured":"Yang, J., Ren, B., Yang, G., et al. (2020). The enhancement of Glycolysis regulates pancreatic cancer metastasis. Cellular and Molecular Life Sciences, 77(2), 305\u2013321. https:\/\/doi.org\/10.1007\/s00018-019-03278-z","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"23","key":"5621_CR11","doi-asserted-by":"publisher","first-page":"e2300898","DOI":"10.1002\/advs.202300898","volume":"10","author":"Q Yang","year":"2023","unstructured":"Yang, Q., Lei, X., He, J., et al. (2023). N4-Acetylcytidine drives Glycolysis addiction in gastric cancer via NAT10\/SEPT9\/HIF-1\u03b1 positive feedback loop. Adv Sci (Weinh), 10(23), e2300898. https:\/\/doi.org\/10.1002\/advs.202300898","journal-title":"Adv Sci (Weinh)"},{"issue":"11","key":"5621_CR12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1530\/erc-17-0058","volume":"24","author":"H Wang","year":"2017","unstructured":"Wang, H., Zhou, R., Sun, L., et al. (2017). TOP1MT deficiency promotes GC invasion and migration via the enhancements of LDHA expression and aerobic Glycolysis. Endocr Relat Cancer, 24(11), 565\u2013578. https:\/\/doi.org\/10.1530\/erc-17-0058","journal-title":"Endocr Relat Cancer"},{"key":"5621_CR13","doi-asserted-by":"publisher","first-page":"110600","DOI":"10.1016\/j.biopha.2020.110600","volume":"130","author":"B Yan","year":"2020","unstructured":"Yan, B., Ren, Z., Sun, J., et al. (2020). IGF2-AS knockdown inhibits Glycolysis and accelerates apoptosis of gastric cancer cells through targeting miR-195\/CREB1 axis. Biomedicine & Pharmacotherapy, 130, 110600. https:\/\/doi.org\/10.1016\/j.biopha.2020.110600","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1","key":"5621_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3892\/or.2018.6423","volume":"40","author":"H Liu","year":"2018","unstructured":"Liu, H., Du, S., Lei, T., et al. (2018). Multifaceted regulation and functions of YAP\/TAZ in tumors (Review). Oncology Reports, 40(1), 16\u201328. https:\/\/doi.org\/10.3892\/or.2018.6423","journal-title":"Oncology Reports"},{"key":"5621_CR15","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.biopha.2017.08.091","volume":"95","author":"C Lin","year":"2017","unstructured":"Lin, C., & Xu, X. (2017). YAP1-TEAD1-Glut1 axis dictates the oncogenic phenotypes of breast cancer cells by modulating Glycolysis. Biomedicine & Pharmacotherapy, 95, 789\u2013794. https:\/\/doi.org\/10.1016\/j.biopha.2017.08.091","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"7","key":"5621_CR16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/mc.23307","volume":"60","author":"M Mickle","year":"2021","unstructured":"Mickle, M., Adhikary, G., Shrestha, S., et al. (2021). VGLL4 inhibits YAP1\/TEAD signaling to suppress the epidermal squamous cell carcinoma cancer phenotype. Molecular Carcinogenesis, 60(7), 497\u2013507. https:\/\/doi.org\/10.1002\/mc.23307","journal-title":"Molecular Carcinogenesis"},{"issue":"3","key":"5621_CR17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.devcel.2019.04.014","volume":"49","author":"SM White","year":"2019","unstructured":"White, S. M., Avantaggiati, M. L., Nemazanyy, I., et al. (2019). YAP\/TAZ Inhibition induces metabolic and signaling rewiring resulting in targetable vulnerabilities in NF2-Deficient tumor cells. Developmental Cell, 49(3), 425\u2013443e429. https:\/\/doi.org\/10.1016\/j.devcel.2019.04.014","journal-title":"Developmental Cell"},{"key":"5621_CR18","doi-asserted-by":"publisher","first-page":"108838","DOI":"10.1016\/j.abb.2021.108838","volume":"702","author":"Z He","year":"2021","unstructured":"He, Z., Chen, D., Wu, J., et al. (2021). Yes associated protein 1 promotes resistance to 5-fluorouracil in gastric cancer by regulating GLUT3-dependent glycometabolism reprogramming of tumor-associated macrophages. Archives of Biochemistry and Biophysics, 702, 108838. https:\/\/doi.org\/10.1016\/j.abb.2021.108838","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"5621_CR19","doi-asserted-by":"publisher","unstructured":"Yang, P., Li, Y., Hou, J., et al. (2024). Blockade of a novel MAP4K4-LATS2-SASH1-YAP1 cascade inhibits tumorigenesis and metastasis in luminal breast cancer. Journal of Biological Chemistry, 300(6). https:\/\/doi.org\/10.1016\/j.jbc.2024.107309","DOI":"10.1016\/j.jbc.2024.107309"},{"issue":"6","key":"5621_CR20","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1134\/s0006297920060036","volume":"85","author":"AS Ilnitskaya","year":"2020","unstructured":"Ilnitskaya, A. S., Zhitnyak, I. Y., & Gloushankova, N. A. (2020). Involvement of SASH1 in the maintenance of stable Cell-Cell adhesion. Biochemistry (Mosc), 85(6), 660\u2013667. https:\/\/doi.org\/10.1134\/s0006297920060036","journal-title":"Biochemistry (Mosc)"},{"issue":"11","key":"5621_CR21","doi-asserted-by":"publisher","first-page":"e2469","DOI":"10.1038\/cddis.2016.364","volume":"7","author":"JT Burgess","year":"2016","unstructured":"Burgess, J. T., Bolderson, E., Adams, M. N., et al. (2016). Activation and cleavage of SASH1 by caspase-3 mediates an apoptotic response. Cell Death and Disease, 7(11), e2469. https:\/\/doi.org\/10.1038\/cddis.2016.364","journal-title":"Cell Death and Disease"},{"issue":"1","key":"5621_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jcmgh.2018.08.007","volume":"7","author":"FC Franke","year":"2019","unstructured":"Franke, F. C., M\u00fcller, J., Abal, M., et al. (2019). The tumor suppressor SASH1 interacts with the signal adaptor CRKL to inhibit Epithelial-Mesenchymal transition and metastasis in colorectal cancer. Cell Mol Gastroenterol Hepatol, 7(1), 33\u201353. https:\/\/doi.org\/10.1016\/j.jcmgh.2018.08.007","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"46","key":"5621_CR23","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1038\/s41388-023-02850-z","volume":"42","author":"F Kou","year":"2023","unstructured":"Kou, F., Wu, L., Zheng, Y., et al. (2023). HMGB1\/SET\/HAT1 complex-mediated SASH1 repression drives Glycolysis and metastasis in lung adenocarcinoma. Oncogene, 42(46), 3407\u20133421. https:\/\/doi.org\/10.1038\/s41388-023-02850-z","journal-title":"Oncogene"},{"issue":"1","key":"5621_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3727\/096504016X14570992647203","volume":"24","author":"W Zong","year":"2016","unstructured":"Zong, W., Yu, C., Wang, P., et al. (2016). Overexpression of SASH1 inhibits TGF-\u03b21-Induced EMT in gastric cancer cells. Oncology Research, 24(1), 17\u201323.","journal-title":"Oncology Research"},{"issue":"2","key":"5621_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.33594\/000000359","volume":"55","author":"A Sanjaya","year":"2021","unstructured":"Sanjaya, A., Goenawan, H., Setiawan, I., et al. (2021). Elaborating the physiological role of YAP as a glucose metabolism regulator:a systematic review. Cellular Physiology and Biochemistry, 55(2), 193\u2013205. https:\/\/doi.org\/10.33594\/000000359","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"1","key":"5621_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13578-023-00993-w","volume":"13","author":"Z Wu","year":"2023","unstructured":"Wu, Z., Ge, L., Ma, L., et al. (2023). TPM2 attenuates progression of prostate cancer by blocking PDLIM7-mediated nuclear translocation of YAP1. Cell Biosci, 13(1), 39. https:\/\/doi.org\/10.1186\/s13578-023-00993-w","journal-title":"Cell Biosci"},{"issue":"16","key":"5621_CR27","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.3748\/wjg.v29.i16.2452","volume":"29","author":"WJ Yang","year":"2023","unstructured":"Yang, W. J., Zhao, H. P., Yu, Y., et al. (2023). Updates on global epidemiology, risk and prognostic factors of gastric cancer. World Journal of Gastroenterology, 29(16), 2452\u20132468. https:\/\/doi.org\/10.3748\/wjg.v29.i16.2452","journal-title":"World Journal of Gastroenterology"},{"issue":"1","key":"5621_CR28","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41392-022-01190-w","volume":"7","author":"ZN Lei","year":"2022","unstructured":"Lei, Z. N., Teng, Q. X., Tian, Q., et al. (2022). Signaling pathways and therapeutic interventions in gastric cancer. Signal Transduct Target Ther, 7(1), 358. https:\/\/doi.org\/10.1038\/s41392-022-01190-w","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"5621_CR29","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.biocel.2011.07.012","volume":"43","author":"M Martini","year":"2011","unstructured":"Martini, M., Gnann, A., Scheikl, D., et al. (2011). The candidate tumor suppressor SASH1 interacts with the actin cytoskeleton and stimulates cell-matrix adhesion. International Journal of Biochemistry & Cell Biology, 43(11), 1630\u20131640. https:\/\/doi.org\/10.1016\/j.biocel.2011.07.012","journal-title":"International Journal of Biochemistry & Cell Biology"},{"issue":"1","key":"5621_CR30","doi-asserted-by":"publisher","first-page":"18605","DOI":"10.1038\/s41598-020-75625-1","volume":"10","author":"JT Burgess","year":"2020","unstructured":"Burgess, J. T., Bolderson, E., Adams, M. N., et al. (2020). SASH1 is a prognostic indicator and potential therapeutic target in non-small cell lung cancer. Scientific Reports, 10(1), 18605. https:\/\/doi.org\/10.1038\/s41598-020-75625-1","journal-title":"Scientific Reports"},{"key":"5621_CR31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2147\/ott.S119244","volume":"10","author":"X Gong","year":"2017","unstructured":"Gong, X., Wu, J., Wu, J., et al. (2017). Correlation of SASH1 expression and ultrasonographic features in breast cancer. Onco Targets Ther, 10, 271\u2013276. https:\/\/doi.org\/10.2147\/ott.S119244","journal-title":"Onco Targets Ther"},{"issue":"17","key":"5621_CR32","first-page":"3781","volume":"21","author":"J Xie","year":"2017","unstructured":"Xie, J., Zhang, W., Zhang, J., et al. (2017). Downregulation of SASH1 correlates with poor prognosis in cervical cancer. European Review for Medical and Pharmacological Sciences, 21(17), 3781\u20133786.","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"5621_CR33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.humpath.2018.01.008","volume":"74","author":"N Zhou","year":"2018","unstructured":"Zhou, N., Liu, C., Wang, X., et al. (2018). Downregulated SASH1 expression indicates poor clinical prognosis in gastric cancer. Human Pathology, 74, 83\u201391. https:\/\/doi.org\/10.1016\/j.humpath.2018.01.008","journal-title":"Human Pathology"},{"issue":"4","key":"5621_CR34","doi-asserted-by":"publisher","first-page":"e21470","DOI":"10.1096\/fj.202002495R","volume":"35","author":"J Jaufmann","year":"2021","unstructured":"Jaufmann, J., Franke, F. C., Sperlich, A., et al. (2021). The emerging and diverse roles of the SLy\/SASH1-protein family in health and disease-Overview of three multifunctional proteins. Faseb J, 35(4), e21470. https:\/\/doi.org\/10.1096\/fj.202002495R","journal-title":"Faseb J"},{"issue":"4","key":"5621_CR35","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.3892\/mmr.2016.4946","volume":"13","author":"H Chen","year":"2016","unstructured":"Chen, H., Wang, D., & Liu, Y. (2016). SASH1 inhibits cervical cancer cell proliferation and invasion by suppressing the FAK pathway. Molecular Medicine Reports, 13(4), 3613\u20133618. https:\/\/doi.org\/10.3892\/mmr.2016.4946","journal-title":"Molecular Medicine Reports"},{"key":"5621_CR36","doi-asserted-by":"publisher","first-page":"1091779","DOI":"10.3389\/fphar.2022.1091779","volume":"13","author":"D Zhou","year":"2022","unstructured":"Zhou, D., Duan, Z., Li, Z., et al. (2022). The significance of Glycolysis in tumor progression and its relationship with the tumor microenvironment. Frontiers in Pharmacology, 13, 1091779. https:\/\/doi.org\/10.3389\/fphar.2022.1091779","journal-title":"Frontiers in Pharmacology"},{"key":"5621_CR37","doi-asserted-by":"publisher","unstructured":"P\u00e9rez-Tom\u00e1s, R., & P\u00e9rez-Guill\u00e9n, I. (2020). Lactate in the tumor microenvironment: An essential molecule in cancer progression and treatment. Cancers (Basel), 12(11). https:\/\/doi.org\/10.3390\/cancers12113244","DOI":"10.3390\/cancers12113244"},{"key":"5621_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/tox.24326","author":"Q Meng","year":"2024","unstructured":"Meng, Q., Li, Y., Sun, Z., et al. (2024). Citrulline facilitates the glycolysis, proliferation, and metastasis of lung cancer cells by regulating RAB3C. Environmental Toxicology. https:\/\/doi.org\/10.1002\/tox.24326","journal-title":"Environmental Toxicology"},{"key":"5621_CR39","doi-asserted-by":"publisher","first-page":"e18761429308361","DOI":"10.2174\/0118761429308361240823061634","volume":"17","author":"L Qiong","year":"2024","unstructured":"Qiong, L., Shuyao, X., Shan, X., et al. (2024). Recent advances in the glycolytic processes linked to tumor metastasis. Current Molecular Pharmacology, 17, e18761429308361. https:\/\/doi.org\/10.2174\/0118761429308361240823061634","journal-title":"Current Molecular Pharmacology"},{"issue":"4","key":"5621_CR40","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1111\/cas.15692","volume":"114","author":"MQ Wang","year":"2023","unstructured":"Wang, M. Q., Chen, Y. R., Xu, H. W., et al. (2023). HKDC1 upregulation promotes Glycolysis and disease progression, and confers chemoresistance onto gastric cancer. Cancer Science, 114(4), 1365\u20131377. https:\/\/doi.org\/10.1111\/cas.15692","journal-title":"Cancer Science"},{"issue":"1","key":"5621_CR41","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3233\/cbm-201621","volume":"30","author":"LJ Pei","year":"2021","unstructured":"Pei, L. J., Sun, P. J., Ma, K., et al. (2021). LncRNA-SNHG7 interferes with miR-34a to de-sensitize gastric cancer cells to cisplatin. Cancer Biomark, 30(1), 127\u2013137. https:\/\/doi.org\/10.3233\/cbm-201621","journal-title":"Cancer Biomark"},{"key":"5621_CR42","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2147\/ott.S358008","volume":"15","author":"M Li","year":"2022","unstructured":"Li, M., Che, N., Jin, Y., et al. (2022). CDKN3 overcomes bladder cancer cisplatin resistance via LDHA-Dependent Glycolysis reprogramming. Onco Targets Ther, 15, 299\u2013311. https:\/\/doi.org\/10.2147\/ott.S358008","journal-title":"Onco Targets Ther"},{"issue":"1","key":"5621_CR43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1055\/s-0041-1742277","volume":"42","author":"L Molina","year":"2022","unstructured":"Molina, L., Nejak-Bowen, K., & Monga, S. P. (2022). Role of YAP1 signaling in biliary Development, Repair, and disease. Seminars in Liver Disease, 42(1), 17\u201333. https:\/\/doi.org\/10.1055\/s-0041-1742277","journal-title":"Seminars in Liver Disease"},{"key":"5621_CR44","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ydbio.2020.12.018","volume":"475","author":"F Szulzewsky","year":"2021","unstructured":"Szulzewsky, F., Holland, E. C., & Vasioukhin, V. (2021). YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance. Development Biology, 475, 205\u2013221. https:\/\/doi.org\/10.1016\/j.ydbio.2020.12.018","journal-title":"Development Biology"},{"issue":"2","key":"5621_CR45","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cmet.2018.07.010","volume":"28","author":"JH Koo","year":"2018","unstructured":"Koo, J. H., & Guan, K. L. (2018). Interplay between YAP\/TAZ and metabolism. Cell Metab, 28(2), 196\u2013206. https:\/\/doi.org\/10.1016\/j.cmet.2018.07.010","journal-title":"Cell Metab"},{"issue":"1","key":"5621_CR46","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41420-022-01104-3","volume":"8","author":"T Yu","year":"2022","unstructured":"Yu, T., Liu, Y., Xue, J., et al. (2022). Gankyrin modulated non-small cell lung cancer progression via Glycolysis metabolism in a YAP1-dependent manner. Cell Death Discov, 8(1), 312. https:\/\/doi.org\/10.1038\/s41420-022-01104-3","journal-title":"Cell Death Discov"},{"issue":"6","key":"5621_CR47","doi-asserted-by":"publisher","first-page":"107309","DOI":"10.1016\/j.jbc.2024.107309","volume":"300","author":"P Yang","year":"2024","unstructured":"Yang, P., Li, Y., Hou, J., et al. (2024). Blockade of a novel MAP4K4-LATS2-SASH1-YAP1 cascade inhibits tumorigenesis and metastasis in luminal breast cancer. Journal of Biological Chemistry, 300(6), 107309. https:\/\/doi.org\/10.1016\/j.jbc.2024.107309","journal-title":"Journal of Biological Chemistry"},{"issue":"41","key":"5621_CR48","doi-asserted-by":"publisher","first-page":"6723","DOI":"10.1038\/s41388-019-0928-x","volume":"38","author":"S-Y Liao","year":"2019","unstructured":"Liao, S-Y., Kuo, I-Y., Chen, Y-T., et al. (2019). AKT-mediated phosphorylation enhances protein stability and transcription activity of ZNF322A to promote lung cancer progression. Oncogene, 38(41), 6723\u20136736.","journal-title":"Oncogene"},{"issue":"1","key":"5621_CR49","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12964-022-00898-0","volume":"20","author":"W Su","year":"2022","unstructured":"Su, W., Hu, H., Ding, Q., et al. (2022). NEK2 promotes the migration and proliferation of ESCC via stabilization of YAP1 by phosphorylation at Thr-143. Cell Commun Signal, 20(1), 87. https:\/\/doi.org\/10.1186\/s12964-022-00898-0","journal-title":"Cell Commun Signal"},{"issue":"3","key":"5621_CR50","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3390\/biomedicines11030734","volume":"11","author":"I Ghosh","year":"2023","unstructured":"Ghosh, I., Khalil, M. I., Mirza, R., et al. (2023). NEK1-Mediated phosphorylation of YAP1 is key to prostate cancer progression. Biomedicines, 11(3), 734.","journal-title":"Biomedicines"},{"issue":"27","key":"5621_CR51","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1038\/s41388-020-1356-7","volume":"39","author":"K Jiang","year":"2020","unstructured":"Jiang, K., Liu, P., Xu, H., et al. (2020). SASH1 suppresses triple-negative breast cancer cell invasion through YAP-ARHGAP42-actin axis. Oncogene, 39(27), 5015\u20135030. https:\/\/doi.org\/10.1038\/s41388-020-1356-7","journal-title":"Oncogene"},{"issue":"3","key":"5621_CR52","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cub.2014.11.054","volume":"25","author":"L Zhang","year":"2015","unstructured":"Zhang, L., Tang, F., Terracciano, L., et al. (2015). NDR functions as a physiological YAP1 kinase in the intestinal epithelium. Current Biology, 25(3), 296\u2013305. https:\/\/doi.org\/10.1016\/j.cub.2014.11.054","journal-title":"Current Biology"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05621-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-026-05621-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05621-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T03:29:24Z","timestamp":1782098964000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-026-05621-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5621"],"URL":"https:\/\/doi.org\/10.1007\/s12010-026-05621-0","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"4 February 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was formally approved by Shaanxi Provincial People\u2019s Hospital, and all patients signed the informed consent before surgery.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}